NCT03387501

Concentrate of Autologous Rich Plasma in Growth Factors in the Treatment of the Thin Endometrium

Efficacy and Safety of the Concentrate of Autologous Rich Plasma in Growth Factors in the Treatment of the Thin Endometrium in Patients Undergoing Transfer of Cryo-preserved Embryos: Clinical Trial II.

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 13 (actual)
• Sponsor: Sara Rafael Fernandez · Academic / Other
• Sex: Female
• Age: 18 Years – 40 Years
• Healthy volunteers: Not accepted

Summary

This study evaluate the percentage of women with thin endometrium who achieve an endometrial thickness equal to or greater than 7 mm after administration of PRGF (plasma rich in growth factors)

Conditions

• Infertility
• Infertility, Female

Interventions

Type	Name	Description
DRUG	Plasma rich in growth factors (PRGF-Endoret)	Intrauterine administration of PRGF

Timeline

• Start date: 2019-05-27
• Primary completion: 2022-07-26
• Completion: 2022-07-26
• First posted: 2018-01-02
• Last updated: 2022-09-08

Locations

1 site across 1 country: Spain